Run Wang
Key Laboratory Of Post Trauma Neuro Repair And Regeneration In Central Nervous System
Tianjin, 300052, China
Tianjin, 300052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: Recruitment of LEF1 by Pontin chromatin modifier amplifies TGFBR2 transcription and activates TGFβ/SMAD signalling during gliomagenesis.
Journal: Cell death & disease
Published: July 09, 2024
Recruitment of LEF1 by Pontin chromatin modifier amplifies TGFBR2 transcription and activates TGFβ/SMAD signalling during gliomagenesis.
Journal: Cell death & disease
Published: April 22, 2022
The ATPase Pontin is a key cell cycle regulator by amplifying E2F1 transcription response in glioma.
The ATPase Pontin is a key cell cycle regulator by amplifying E2F1 transcription response in glioma.
Journal: Cell death & disease
Published: July 31, 2020
The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma.
Journal: The international journal of biochemistry & cell biology
Published: February 09, 2019
miR-361-5p inhibits glioma migration and invasion by targeting SND1.
Journal: OncoTargets and therapy
Published: September 15, 2018
miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis.
Journal: Cell death & disease
Published: May 21, 2018
miR-135a-5p Functions as a Glioma Proliferation Suppressor by Targeting Tumor Necrosis Factor Receptor-Associated Factor 5 and Predicts Patients' Prognosis.
Journal: The American journal of pathology
Published: March 07, 2018
Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
Journal: The Journal of clinical investigation
Published: February 06, 2018
miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.
Journal: British journal of cancer
Published: June 15, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026